Can AAV continue to deliver the promise of gene therapy?
Ratish Krishnan, Elie Hanania
14 September 2023
Podcast
Non-viral methods for ex vivo cell & gene therapy: is the future non-viral?
Valeria Annibaldi, Andrea Toell
Solving challenges in cell therapy clinical trials & effectively delivering complex studies in advanced therapeutics
Jai Balkissoon, Vito Romita
Challenges in cryogenic storage containers for cell & gene therapy
Alex Sargent, Sean Werner
Maximizing efficiency & flexibility in viral vector manufacturing scale-up
D Kole, J Petrone, M Bisschops et al
Shear ignorance? Think again: breaking the perception of shear within viral vector manufacturing
Ratish Krishnan, Akshat Gupta
Tales, tips & teachable moments from applications support veterans
Chris Suarez, Catherine Siler, Austin Mogen
Working together to safely advance cell & gene therapies
J Maher, A J King, F Neethling et al
12 September 2022
Podcast
Achieving better AAV vector productivity and product quality
Diane Golebiowski, Marissa Stanvick
Where will tomorrow’s workforce come from? PART 3: Innovation in staff sourcing, training and retention - what works and what doesn’t?
S Kili, M Lehmicke, Q Rafiq et al
Where will tomorrow’s workforce come from? Part 2: How is the educational system responding, and how can the cell and gene therapy community at large help?
S Kili, M Lehmicke, Q Rafiq et al